6r.ai is an artificial intelligence-machine learning automation firm (see business plan) utilizing robotics and ai agents to automate small to medium sized businesses. The first target buyout businesses will be veterinarians, mortuaries, and testing facilities. Automation is presented in 3 phases with the following in mind:
Robotic automation and AI Agents are presented as a way to increase profits by eliminating many expenses.
Our algorithms learn about your specific business with high accuracy. Just turn it on and it does the rest through automation. Initially tested in residences, work areas, farming, greenhouses, medical settings and meat packing facilities to name a few.
The tech platform also recognizes matter in air, water and on surfaces using automated drones and robots that detect all types of matter including bacteria, viruses, fungus, allergens, toxins, pathogens and microbes, contaminates, and pollutants. Scaled up to a more robust version, 6r can also detect germs and biological agents and sequester them safely. In medical settings, animal bodily fluids, tissue samples, as well as parasites in stool samples can be detected using AI.
Provides honest results with no political or financial persuasions. No opinions, just facts, no outside influences to alter results.
Offers ongoing respect for the environment, living beings and our stakeholders.
Forms new ways to conduct business through Ai Agent intervention. 6r AI Agents will automate most of the company operations after funding levels reach milestones.
Phase I
The automation of all back office electronic and testing data, customer relationship management (CRM) utilizing swarming of AI agents. Swarming refers to the collective behavior of multiple autonomous AI agents working together to perform complex tasks without human intervention.
Phase II
Physical tasks presently completed by support staff will be transitioned into robotic applications through training of hybrid algorithms and AI agents.
Phase III
The business will be monitored by one to five trained professionals whereby most of the businesses will be managed by ai agents directing robots and drones.
As of 2026, development was completed with automated robotics through self directed AI Agents to perform physical tasks. Since 2018, the company through its founding technology platform completed research and development in artificial intelligence, machine learning, and ai agents by automating procedures and applications whereby patent applications were filed with the united states patent and trademark office and the world intellectual patent organization (USPTO/WIPO). The research and development initially was based on automated matter detection. Presently, the company is researching quantum computing and quantum technologies that may increase accuracy and the speed of automation, ai agents, and robots (including drones).
On February 6, 2026, DeTection Inc. filed patent applications with the United States Patent and Trademark Office "USPTO" and the World Intellectual Patent Organization "WIPO" for Self Directed Robotic Medical Procedures.
AI machines will be trained in the same manner as doctors with manual labor or self-training. AI application training and regulatory approvals will vary in durations. Regulatory approvals durations outside of the United States will be shorter. Investors in DeTection Inc. will also own the IP in the autonomous medical procedures. Click on Automated Medical Apps for more information.
More than 3 states can be used with 6r detection- coming in 2030.
Self learning algorithms are used with the 6r.
Building a database with matter detection.
